Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness

被引:52
|
作者
Fox, Matthew P. [1 ,2 ,3 ]
Rosen, Sydney [1 ,2 ]
Geldsetzer, Pascal [4 ]
Baernighausen, Till [4 ,5 ,6 ]
Negussie, Eyerusalem [7 ]
Beanland, Rachel [7 ]
机构
[1] Boston Univ, Dept Global Hlth, 801 Massachusetts Ave, Boston, MA 02118 USA
[2] Univ Witwatersrand, Hlth Econ & Epidemiol Res Off, Dept Internal Med, Sch Clin Med,Fac Hlth Sci, Johannesburg, South Africa
[3] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA
[4] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA
[5] Africa Hlth Res Inst, Somkhele, South Africa
[6] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany
[7] WHO, Dept HIV AIDS, Geneva, Switzerland
关键词
retention; attrition; interventions; systematic review; meta-analysis; linkage; art initiation; SOUTH-AFRICA; CARE; RETENTION; LINKAGE; INTEGRATION; SERVICES; UGANDA; ART; SETTINGS; ADULTS;
D O I
10.7448/IAS.19.1.20888
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: As global policy evolves toward initiating lifelong antiretroviral therapy (ART) regardless of CD4 count, initiating individuals newly diagnosed with HIV on ART as efficiently as possible will become increasingly important. To inform progress, we conducted a systematic review of pre-ART interventions aiming to increase ART initiation in sub-Saharan Africa. Methods: We searched PubMed, Embase and the ISI Web of Knowledge from 1 January 2008 to 1 March 2015, extended in PubMed to 25 May 2016, for English language publications pertaining to any country in sub-Saharan Africa and reporting on general adult populations. We included studies describing interventions aimed at increasing linkage to HIV care, retention in pre-ART or uptake of ART, which reported ART initiation as an outcome. We synthesized the evidence on causal intervention effects in meta-analysis of studies belonging to distinct intervention categories. Results and discussion: We identified 22 studies, which evaluated 25 interventions and included data on 45,393 individual patients. Twelve of twenty-two studies were observational. Rapid/point-of-care (POC) CD4 count technology (seven interventions) (relative risk, RR: 1.26; 95% confidence interval, CI: 1.02-1.55), interventions within home-based testing (two interventions) (RR: 2.00; 95% CI: 1.36-2.92),improved clinic operations (three interventions) (RR: 1.36; 95% CI: 1.25-1.48)and a package of patient-directed services (three interventions) (RR: 1.54; 95% CI: 1.20-1.97)were all associated with increased ART initiation as was HIV/TB service integration (three interventions) (RR: 2.05; 95% CI: 0.59-7.09)but with high imprecision. Provider-initiated testing (three interventions) was associated with reduced ART initiation (RR: 0.91; 95% CI: 0.86-0.97). Counselling and support interventions (two interventions) (RR 1.08; 95% CI: 0.94-1.26) had no impact on ART initiation. Overall, the evidence was graded as low or moderate quality using the GRADE criteria. Conclusions: The literature on interventions to increase uptake of ART is limited and of mixed quality. POC CD4 count and improving clinic operations show promise. More implementation research and evaluation is needed to identify how best to offer treatment initiation in a manner that is both efficient for service providers and effective for patients without jeopardizing treatment outcomes.
引用
收藏
页数:14
相关论文
共 50 条
  • [11] Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis
    Mugglin, Catrina
    Estill, Janne
    Wandeler, Gilles
    Bender, Nicole
    Egger, Matthias
    Gsponer, Thomas
    Keiser, Olivia
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 (12) : 1509 - 1520
  • [12] Interventions to improve early retention of patients in antiretroviral therapy programmes in sub-Saharan Africa: A systematic review
    Muhula, Samuel
    Gachohi, John
    Kombe, Yeri
    Karanja, Simon
    [J]. PLOS ONE, 2022, 17 (02):
  • [13] Delivery of antiretroviral therapy in sub-Saharan Africa
    Weller, Ian
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (06) : 777 - 778
  • [14] Early versus Delayed Initiation of Antiretroviral Therapy for Concurrent HIV Infection and Cryptococcal Meningitis in Sub-Saharan Africa
    Makadzange, Azure T.
    Ndhlovu, Chiratidzo E.
    Takarinda, Kudakwashe
    Reid, Michael
    Kurangwa, Magna
    Gona, Philimon
    Hakim, James G.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (11) : 1532 - 1538
  • [16] Timing of Antiretroviral Therapy and Systemic Inflammation in Sub-Saharan Africa: Results From the META Longitudinal Cohort Study
    Siedner, Mark J.
    Bwana, Mwebesa Bosco
    Asiimwe, Stephen
    Amanyire, Gideon
    Musinguzi, Nicholas
    Castillo-Mancilla, Jose
    Tracy, Russell P.
    Katz, Ingrid T.
    Bangsberg, David R.
    Hunt, Peter W.
    Orrell, Catherine
    Haberer, Jessica E.
    Ware, Norma
    Elioda, Tumwesigye
    Tsai, Alexander C.
    Matthews, Lynn
    Wyatt, Monique
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (07): : 1172 - 1177
  • [17] Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy
    Peterson, Kevin
    van Griensven, Johan
    in 't Veld, Diana Huis
    Colebunders, Robert
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (01) : 43 - 50
  • [18] Determinants of antiretroviral therapy coverage in Sub-Saharan Africa
    Furuoka, Fumitaka
    Hoque, Mohammad Zahirul
    [J]. PEERJ, 2015, 3
  • [19] Antiretroviral therapy in sub-Saharan Africa: myth or reality?
    Kebba, A
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (05) : 747 - 749
  • [20] Cultivating a universal understanding of ART adherence: Comments on "A meta-analysis of effectiveness of interventions to improve adherence in pregnant women receiving antiretroviral therapy in sub-Saharan Africa"
    Omonaiye, Olumuyiwa
    Nicholson, Pat
    Kusljic, Snezana
    Manias, Elizabeth
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 100 : 50 - 52